Study Evaluating Pantoprazole in Peptic Ulcer Hemorrhage
Completed · Phase 2
Conditions studied: Peptic Ulcer Hemorrhage
In brief
This is a multicenter, randomized, double-blind, parallel-group, dose-ranging, comparator-controlled study of the effect of pantoprazole on intragastric pH after successful endoscopic hemostasis in hospitalized patients. Patients will receive either intravenous pantoprazole (one of two regimens) or ranitidine (the comparator) within 2 hours of successful hemostasis and administration will continue for 72 hours after hemostasis.
Key facts
- Study ID
- NCT00037570
- Run by
- Wyeth is now a wholly owned subsidiary of Pfizer
- People needed
- 12
- Starts
- 2000-11-01
- Expected to finish
- 2002-02-01
- Last updated by the study team
- 2013-02-08
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Patients must be men or nonpregnant women at least 18 years of age
- Patients who present with a gastric or duodenal ulcer (major dimension of the ulcer must be ≥ 5 mm and ≤ 20 mm) with endoscopic appearance of spurting, oozing, or nonbleeding visible vessel (NBVV) Patients presenting with adherent protruding clot are eligible if, after removal of the clot by irrigation, the underlying lesion is classified as spurting, oozing or a NBVV. Patients with an actively bleeding ulcer or a NBVV within a hiatal hernia are eligible if the ulcer is located below the Z-line)
You may not qualify if…
- Patients with ulcer appearance of clean base (non-oozing, non-spurting) or flat pigmented spot; adherent clots not removed by irrigation
- Patients presenting with active bleeding and/or NBVV at 2 or more separate sites
- Patients with any severe concomitant diseases, eg, end-stage liver or renal disease, or unstable cardiovascular, pulmonary, renal, hepatic, or gastrointestinal diseases
Where it is running
- Study site — Los Angeles, California, United States
- Study site — San Diego, California, United States
- Study site — Cincinnati, Ohio, United States
- Study site — Philadelphia, Pennsylvania, United States
- Study site — Houston, Texas, United States
- Study site — Norfolk, Virginia, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.